
0:00
37:50
Join Professor Peter Nash from Griffith University in Brisbane and Doctor Mark Gibson from the Centre for Rheumatic Diseases, King’s College London, as they discuss Doctor Gibson’s recent paper, ‘Cancer risk of Janus kinase inhibitors and other advanced therapies in immune-mediated inflammatory diseases: a systematic review and Bayesian network meta-analysis of RCTs’.
Flere episoder fra "The IMID Forum"



Gå ikke glip af nogen episoder af “The IMID Forum” - abonnér på podcasten med gratisapp GetPodcast.








